Literature DB >> 24832821

Characteristics of chronic noncancer pain patients assessed with the opioid risk tool in a Canadian tertiary care pain clinic.

Shehnaz Fatima Lakha1, Ada F Louffat, Keith Nicholson, Amol Deshpande, Angela Mailis-Gagnon.   

Abstract

BACKGROUND: The Opioid Risk Tool (ORT) is a screening instrument for assessing the risk of opioid-related aberrant behavior in chronic noncancer pain (CNCP) patients.
OBJECTIVE: This study aims to compare patient characteristics documented in the original ORT study with those identified in CNCP patients assessed using a physician-administered ORT in a tertiary care pain clinic in Toronto, Canada.
METHODOLOGY: This was a descriptive cross-sectional study of 322 consecutive new patients referred over 12 months. Data extraction included ORT scores, demographics, pain ratings, opioid, and other medication use at point of entry, diagnosis, and other variables. Characteristics were compared with those described in the original ORT study.
RESULTS: The total mean ORT scores of patients in this study were related to several demographic (gender, age, marital status, and country of birth) and nondemographic variables (employment status, cigarette smoking, and contribution of biomedical and/or psychological factors to presentation). Prevalence of characteristics noted in this patient sample differed substantially from that found in Webster and Webster as the basis for ORT scores.
CONCLUSION: Significant differences existed between this study population and the patient sample from which the ORT was derived. Limitations of this study are discussed. We concur with the authors of the original study that the ORT may not be applicable in different pain populations and settings. Based on our findings, we encourage caution in interpreting the ORT in general CNCP settings until further studies are performed. Wiley Periodicals, Inc.

Entities:  

Keywords:  Chronic Noncancer Pain; Opioid Risk Tool; Opioids; Tertiary Care Center

Mesh:

Year:  2014        PMID: 24832821     DOI: 10.1111/pme.12465

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  4 in total

1.  Survey of Opioid Risk Tool Among Cancer Patients Receiving Opioid Analgesics.

Authors:  So Yeon Oh; Kwonoh Park; Su-Jin Koh; Jung Hun Kang; Myung Hee Chang; Kyung Hee Lee
Journal:  J Korean Med Sci       Date:  2022-06-13       Impact factor: 5.354

2.  Prevalence and incidence of prescription opioid analgesic use in Australia.

Authors:  Samanta Lalic; Jenni Ilomäki; J Simon Bell; Maarit Jaana Korhonen; Natasa Gisev
Journal:  Br J Clin Pharmacol       Date:  2018-11-16       Impact factor: 4.335

3.  Application of risk assessment tools to predict opioid usage after shoulder surgery.

Authors:  Laila H Khoury; Josh Stephens; Shimron Brown; Kiran Chatha; Sarah Girshfeld; Juan Manuel Lozano Leon; Alessia Lavin; Vani J Sabesan
Journal:  JSES Int       Date:  2022-07-03

4.  Cross-sectional study of the prevalence of prescription opioids misuse in French patients with chronic non-cancer pain: An update with the French version of the POMI scale.

Authors:  Nicolas Kerckhove; Noémie Delage; Célian Bertin; Emmanuelle Kuhn; Nathalie Cantagrel; Caroline Vigneau; Jessica Delorme; Céline Lambert; Bruno Pereira; Chouki Chenaf; Nicolas Authier
Journal:  Front Pharmacol       Date:  2022-09-05       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.